News | August 11, 2021
GSK files application for MMR vaccine in the US
If approved it will bring a second source of MMR vaccine to the US market
If approved it will bring a second source of MMR vaccine to the US market
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
This robust growth has come despite the raging pandemic for most part of the quarter
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
Subscribe To Our Newsletter & Stay Updated
